期刊文献+

沉默缺氧诱导因子1α可抑制携带C-kit基因突变的急性髓细胞白血病细胞增殖

Effect of hypoxia-inducible factor 1α in inhibiting cellular proliferation of acute myeloid leukemia carrying C-kit mutation
在线阅读 下载PDF
导出
摘要 目的探讨抑制C-kit基因突变阳性的t(8;21)急性髓系白血病(acute myeloid leukemia,AML)细胞中缺氧诱导因子1α(hypoxia inducible factor 1α,HIF1α)对C-kit表达及细胞恶性生物学行为的影响。方法采用不同浓度的HIF1α特异性抑制剂棘霉素处理两种携带C-kit基因突变的t(8;21)AML细胞系Kasumi-1和SKNO-124h,以二甲基亚砜处理的细胞作为对照组。采用实时定量RT-PCR检测细胞中HIF1α、C-kit基因mRNA表达水平,Western blot检测蛋白表达水平,AnnexinV-PI双染后流式细胞仪检测细胞凋亡,克隆形成实验检测细胞体外克隆形成能力。结果棘霉素能明显抑制Kasumi-1和SKNO-1细胞中HIF1α基因和C-kit基因mRNA和蛋白的表达水平,且该抑制作用具有浓度依赖性,同时细胞增殖被抑制、细胞凋亡增加。结论棘霉素靶向抑制HIF1α可通过下调C-kit表达抑制携带C-kit基因突变的t(8;21)AML细胞增殖,该作用与棘霉素诱导的细胞凋亡有关。 Objective To investigate the effect of silencing of hypoxia inducible factor 1α(HIF1α)on the expression of C-kit gene and cellular malignant biological behavior in t(8;21)AML carrying C-kit gene mutation.Methods Two t(8;21)AML cell lines carrying C-kit gene mutation,Kasumi-1 and SKNO-1,were respectively treated with different concentration of HIF1αspecific inhibitors echinomycin(1 nmol/L,5 nmol/L,10 nmol/L,20 nmol/L,30 nmol/L,respectively).The cells were harvested at 24 hours after treatment,and those treated with dimethyl sulfoxide were selected as control group.Real-time quantitative RT-PCR was used to detect the HIF1αand C-kit gene mRNA expression levels,Western blot for protein expression levels,AnnexinV-PI double staining followed by flow cytometry for cellular apoptosis,and Colony-forming assay for cellular proliferation in vitro.Results Echinomycinsignificantly inhibited the mRNA and protein expression levels of HIF1αand C-kit genes in Kasumi-1 and SKNO-1 cells with a concentration-dependent manner.The proliferation of both cell lines was inhibited and cellular apoptosis increased.Conclusion Targeted inhibition of HIF1αusing echinomycin can inhibit the proliferation of t(8;21)AML cells carrying C-kit gene mutation by down-regulating the expression of C-kit,which is related to the increased cellular apoptosis caused by echinomycin.
作者 陈泽 张继彬 吕娜 李永辉 周薇 关伟 高晓宁 CHEN Ze;ZHANG Jibin;LYU Na;LI Yonghui;ZHOU Wei;GUAN Wei;GAO Xiaoning(Department of Hematology,Chinese PLA General Hospital,Beijing 100853,China;Department of Cardiology the First Medical Center,Chinese PLA General Hospital,Beijing 100853,China)
出处 《解放军医学院学报》 CAS 2020年第6期608-613,643,共7页 Academic Journal of Chinese PLA Medical School
基金 国家自然科学基金项目(81870109,81670135)
关键词 急性髓细胞白血病 C-kit突变 缺氧诱导因子1Α 细胞增殖 细胞周期 acute myeloid leukemia C-kit mutation hypoxia inducible factor 1α proliferation cell cycle
作者简介 陈泽,女,在读硕士。研究方向:白血病的发病机制。Email:cz13021099727@163.com;通信作者:高晓宁,女,副主任医师,副教授,硕士生导师。Email:gaoxn@263.net
  • 相关文献

参考文献1

二级参考文献7

  • 1Buchdunger E, Cioffi CL, Law N, et al. Abl protein-tyrosine kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c-kit and platelet-derived growth factor receptors. J Pharmacal Exp Ther,2000, 295:139-145.
  • 2Heinrich MC, Griffith DJ, Druker BJ,et al. Inhibition of c-kit receptor tyrosine kinase activity by STI571, a selective tyrosine kinase inhibitor. Blood, 2000, 96:925-932.
  • 3Beghini A, Magnani I, Ripamonti CB, et al. Amplication of a novel c-kit activating mutation Asn822-Lys in the Kasumi-1 cell line: a t(8;21 )-Kit mutant model for acute myeloid leukemia. Hematol J,2002, 3:157-163.
  • 4Fritsche-Polanz R, Jordan JH, Feix A, et al. Mutation analysis of CKIT in patients with myelodysplastic syndromes without mastocytosis and cases of systemic mastocytosis. Br J Haematol, 2001,113: 357-364.
  • 5Scandura JM, Boccuni P, Cammenga J, et al. Transcription factor fusions in acute leukemia: variations on a theme. Oncogene, 2002,21: 3422-3444.
  • 6Mesters RM, Padro T, Bieker R, et al. Stable remission after administration of the receptor tyrosine kinase inhibitor SU5416 in a patient with refractory acute myeloid leukemia. Blood, 2001, 98:241-243.
  • 7Kindler T, Breitenbuecher F, Marx A, et al. Sustained complete hematologic remission after administration of the tyrosine kinase inhibitor imatinib mesylate in a patient with refractory, secondary AML.Blood, 2003, 101:2960-2962.

共引文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部